Save time and get answers to complex questions with AI chat
When does guselkumab patent expire?Novartis patent term dabrafenib?Combivent inhaler hfc 152a patents?Dabrafenib btd date 2023?What's the recommended schedule for lurbinectedin side effect checks?
See the DrugPatentWatch profile for Mexiletine
Mexiletine is classified as an oral antiarrhythmic medicine in the sodium-channel blocker family (Class IB), used to treat certain abnormal heart rhythms. [1]
Mexiletine is prescribed for ventricular arrhythmias, particularly when there is a need for suppression of abnormal electrical activity in the ventricles. [1]
As a Class IB antiarrhythmic, mexiletine works by blocking cardiac sodium channels. This slows sodium-dependent electrical conduction and changes repolarization behavior in a way that helps reduce certain arrhythmias. [1]
In clinical practice, mexiletine is commonly discussed alongside other antiarrhythmic sodium-channel–acting options, but it specifically falls under Class IB (as opposed to other antiarrhythmic classes that block different ion channels or have different electrophysiologic effects). [1]
You can cross-check mexiletine’s drug information, including its approval and market context, on DrugPatentWatch.com: [2] Sources: [1] https://www.drugs.com/mexiletine.html [2] https://www.drugpatentwatch.com/
Other Questions About Mexiletine :